登出

自選
模擬交易
選股器
熱力圖
機構追踪

美股市場個股詳情

ALKS 阿爾凱默斯

添加自選

24.680
+0.240+0.98%

收盤價 04/26 16:00 (美東)

24.680
0.0000.00%

盤後 16:20 (美東)

41.75億總市值11.75市盈率TTM

阿爾凱默斯股票討論區

登錄發表評論

Nancy S. Lurker's appointment to Alkermes' Board is viewed positively, bringing deep industry experience and commercial expertise. Her broad skills are expected to drive growth of existing products, portfolio expansion, and new product launches.

Press Release: Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Alkermes' surplus of cash over debt and its ability to convert EBIT to free cash flow indicate a conservative balance sheet and low risk in its debt management.

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

2023/10/13 18:48

Although Alkermes' share price has recently dipped, its long-term business trends are positive. Insider purchases, often seen as a good omen by investors, add further optimism.

Alkermes (NASDAQ:ALKS) Shareholders Are Still up 59% Over 3 Years Despite Pulling Back 3.8% in the Past Week

逍遥投资派

2023/05/20 23:11

$阿爾凱默斯(ALKS.US)$5年來營收波動中變化不大，營業利潤和淨利潤持續虧損5年，虧損情況沒有改善跡象。
2023Q1營收增長3.3%，營業利潤和淨利潤虧損均大幅擴大，目前看不到投資價值。

已翻譯

2023/01/06 16:58

$阿爾凱默斯(ALKS.US)$ huge call options in dec, unusual. buyout for JPM healthcare conference next week?

Moomoo Breakfast US

2022/04/07 20:52

專欄Today's pre-market stock movers: ANGO, SKIL, CXM, HPQ and more

Gainers:
• $AngioDynamics(ANGO.US)$ +13.5%, $Skillsoft(SKIL.US)$ +3.26%, $Sprinklr(CXM.US)$ +8.96%, $Cazoo(CZOO.US)$ +11.1%, $Apogee Enterprises(APOG.US)$ +3.3%, $李維斯(LEVI.US)$ +1.7%, $星座品牌(STZ.US)$ + 0.8%
• $Momentus(MNTS.US)$ +36.9% (signed multiple launch agreements with Space Exploration Technologies Corp)
• $惠普(HPQ.US)$ +10.1% (Berkshire Hathaway's Warren Buffett disclosed the purchase of mln sh...

15

3

2021/06/01 19:44

Just got FDA approved and have another drug phase1/2 on 4 June!!

$阿爾凱默斯(ALKS.US)$

Just got FDA approved and have another drug phase1/2 on 4 June!!

曬曬你今日的盈虧

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

美股

綜合熱度